TIDMSBS

RNS Number : 6588D

Nplus1 Singer Capital Markets Ltd

08 July 2016

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Name of exempt principal trader:                                            Nplus1 Singer Capital Markets Limited 
------------------------------------------------------------------------------  -------------------------------------- 
 (b) Name of offeror/offeree in relation to whose relevant securities this 
 form relates:                                                                     Source Bioscience Plc 
 Use a separate form for each offeror/offeree 
------------------------------------------------------------------------------  -------------------------------------- 
 (c) Name of the party to the offer with which exempt principal trader is 
 connected:                                                                        Source Bioscience Plc 
------------------------------------------------------------------------------  -------------------------------------- 
 (d) Date dealing undertaken:                                                    07 July 2016 
------------------------------------------------------------------------------  -------------------------------------- 
 (e) Has the EPT previously disclosed, or is it today disclosing, under the      Yes 
 Code in respect 
 of any other party to this offer? 
------------------------------------------------------------------------------  -------------------------------------- 
 
   2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER 
   (a)        Purchases and sales 
 
    Class of relevant      Purchases/ sales       Total number of         Highest price per     Lowest price per unit 
        security                                     securities          unit paid/received         paid/received 
------------------------  ------------------  -----------------------  ----------------------  ----------------------- 
 
          ORD 2P                Purchase                75000                   17.501p                 17.501p 
------------------------  ------------------  -----------------------  ----------------------  ----------------------- 
 
          ORD 2P                  Sales                 100000                   17.7p                   17.7p 
------------------------  ------------------  -----------------------  ----------------------  ----------------------- 
 
   (b)        Derivatives transactions (other than options) 
 
    Class of relevant       Product description      Nature of dealing         Number of reference      Price per unit 
         security                 e.g. CFD         e.g. opening/closing a           securities 
                                                    long/short position, 
                                                   increasing/reducing a 
                                                    long/short position 
-------------------------  --------------------  -------------------------  -------------------------  --------------- 
 
 
   (c)        Options transactions in respect of existing securities 
   (i)         Writing, selling, purchasing or varying 
 
   Class of       Product        Writing,      Number of       Exercise          Type       Expiry date   Option money 
   relevant     description    purchasing,     securities      price per         e.g.                        paid/ 
   security      e.g. call       selling,       to which         unit         American,                   received per 
                   option      varying etc.      option                        European                       unit 
                                                relates                          etc. 
-------------  -------------  -------------  -------------  --------------  -------------  ------------  ------------- 
 
 
   (ii)        Exercising 
 
 Class of relevant security   Product description   Number of securities   Exercise price per unit 
                                e.g. call option 
---------------------------  --------------------  ---------------------  ------------------------ 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant security         Nature of dealing          Details   Price per unit (if applicable) 
                               e.g. subscription, conversion 
---------------------------  -------------------------------  --------  ------------------------------- 
 
 

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

   3.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the exempt principal trader making the disclosure and any party 
  to the offer or any person acting in concert with a party to the offer: 
  If there are no such agreements, arrangements or understandings, state "none" 
---------------------------------------------------------------------------------------------- 
 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the exempt 
  principal trader making the disclosure and any other person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
----------------------------------------------------------------------------------------------- 
 
 
 
 Date of disclosure:    08 July 2016 
---------------------  ----------------- 
 Contact name:          Damian Fernandez 
---------------------  ----------------- 
 Telephone number:      020 7496 3093 
---------------------  ----------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

FERGMGGNRRFGVZG

(END) Dow Jones Newswires

July 08, 2016 04:04 ET (08:04 GMT)

Source Bioscience (LSE:SBS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Source Bioscience
Source Bioscience (LSE:SBS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Source Bioscience